Cargando…

First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling

BACKGROUND: The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a looming threat to human health. Although there are numerous studies regarding porin alteration in association with the production of ESBLs and/or AmpC β-lactamase, a systematic study on the treatment-emergence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xuebin, Wang, Qiongdan, Perlaza-Jiménez, Laura, Zheng, Xiangkuo, Zhao, Yajie, Dhanasekaran, Vijay, Fang, Renchi, Li, Jiahui, Wang, Chong, Liu, Haiyang, Lithgow, Trevor, Cao, Jianming, Zhou, Tieli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372807/
https://www.ncbi.nlm.nih.gov/pubmed/32689945
http://dx.doi.org/10.1186/s12866-020-01898-1
_version_ 1783561386464378880
author Tian, Xuebin
Wang, Qiongdan
Perlaza-Jiménez, Laura
Zheng, Xiangkuo
Zhao, Yajie
Dhanasekaran, Vijay
Fang, Renchi
Li, Jiahui
Wang, Chong
Liu, Haiyang
Lithgow, Trevor
Cao, Jianming
Zhou, Tieli
author_facet Tian, Xuebin
Wang, Qiongdan
Perlaza-Jiménez, Laura
Zheng, Xiangkuo
Zhao, Yajie
Dhanasekaran, Vijay
Fang, Renchi
Li, Jiahui
Wang, Chong
Liu, Haiyang
Lithgow, Trevor
Cao, Jianming
Zhou, Tieli
author_sort Tian, Xuebin
collection PubMed
description BACKGROUND: The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a looming threat to human health. Although there are numerous studies regarding porin alteration in association with the production of ESBLs and/or AmpC β-lactamase, a systematic study on the treatment-emergence of porins alteration in antibiotic resistance does not yet exist. The aim of this study was to investigate the underlying mechanism of resistance of K. pneumoniae during carbapenem treatment. RESULTS: Here, we report three strains (FK-2624, FK-2723 and FK-2820) isolated from one patient before and after imipenem treatment during hospitalization. Antibiotic susceptibility testing indicated that that the first isolate, FK-2624, was susceptible to almost all tested antimicrobials, being resistant only to fosfomycin. The subsequent isolates FK-2723 and FK-2820 were multidrug resistant (MDR). After imipenem therapy, FK-2820 was found to be carbapenem-resistant. PCR and Genome Sequencing analysis indicated that oqxA, and fosA5, were identified in all three strains. In addition, FK-2624 also harbored bla(SHV)(-)(187) and bla(TEM-116). The bla(SHV)(-)(187) and bla(TEM-116) genes were not detected in FK-2723 and FK-2820. bla(DHA)(-1), qnrB4, aac (6′)-IIc, and bla(SHV)(-)(12), EreA2, CatA2, SulI, and tetD, were identified in both FK-2723 and FK-2820. Moreover, the genes bla(DHA)-1, qnrB4, aac (6′)-IIc were co-harbored on a plasmid. Of the virulence factors found in this study, ybtA, ICEKp6, mrkD, entB, iroN, rmpA2–6, wzi16 and capsular serotype K57 were found in the three isolates. The results of pairwise comparisons, multi-locus sequencing typing (MLST) and pulsed-field gel electrophoresis (PFGE) revealed high homology among the isolates. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) results showed that isolate FK-2820 lacked OmpK36, with genome sequence data validating that there was a premature stop codon in the ompK36 gene and real-time RT-PCR suggesting high turnover of the ompK36 non-sense transcript in FK-2820, with the steady-state mRNA level 0.007 relative to the initial isolate. CONCLUSION: This study in China highlight that the alteration of outer membrane porins due to the 14-day use of imipenem play a potential role in leading to clinical presentation of carbapenem-resistance. This is the first description of increased resistance developing from a carbapenem-susceptible K. pneumoniae with imipenem treatment driven by outer membrane remodeling.
format Online
Article
Text
id pubmed-7372807
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73728072020-07-21 First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling Tian, Xuebin Wang, Qiongdan Perlaza-Jiménez, Laura Zheng, Xiangkuo Zhao, Yajie Dhanasekaran, Vijay Fang, Renchi Li, Jiahui Wang, Chong Liu, Haiyang Lithgow, Trevor Cao, Jianming Zhou, Tieli BMC Microbiol Research Article BACKGROUND: The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a looming threat to human health. Although there are numerous studies regarding porin alteration in association with the production of ESBLs and/or AmpC β-lactamase, a systematic study on the treatment-emergence of porins alteration in antibiotic resistance does not yet exist. The aim of this study was to investigate the underlying mechanism of resistance of K. pneumoniae during carbapenem treatment. RESULTS: Here, we report three strains (FK-2624, FK-2723 and FK-2820) isolated from one patient before and after imipenem treatment during hospitalization. Antibiotic susceptibility testing indicated that that the first isolate, FK-2624, was susceptible to almost all tested antimicrobials, being resistant only to fosfomycin. The subsequent isolates FK-2723 and FK-2820 were multidrug resistant (MDR). After imipenem therapy, FK-2820 was found to be carbapenem-resistant. PCR and Genome Sequencing analysis indicated that oqxA, and fosA5, were identified in all three strains. In addition, FK-2624 also harbored bla(SHV)(-)(187) and bla(TEM-116). The bla(SHV)(-)(187) and bla(TEM-116) genes were not detected in FK-2723 and FK-2820. bla(DHA)(-1), qnrB4, aac (6′)-IIc, and bla(SHV)(-)(12), EreA2, CatA2, SulI, and tetD, were identified in both FK-2723 and FK-2820. Moreover, the genes bla(DHA)-1, qnrB4, aac (6′)-IIc were co-harbored on a plasmid. Of the virulence factors found in this study, ybtA, ICEKp6, mrkD, entB, iroN, rmpA2–6, wzi16 and capsular serotype K57 were found in the three isolates. The results of pairwise comparisons, multi-locus sequencing typing (MLST) and pulsed-field gel electrophoresis (PFGE) revealed high homology among the isolates. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) results showed that isolate FK-2820 lacked OmpK36, with genome sequence data validating that there was a premature stop codon in the ompK36 gene and real-time RT-PCR suggesting high turnover of the ompK36 non-sense transcript in FK-2820, with the steady-state mRNA level 0.007 relative to the initial isolate. CONCLUSION: This study in China highlight that the alteration of outer membrane porins due to the 14-day use of imipenem play a potential role in leading to clinical presentation of carbapenem-resistance. This is the first description of increased resistance developing from a carbapenem-susceptible K. pneumoniae with imipenem treatment driven by outer membrane remodeling. BioMed Central 2020-07-20 /pmc/articles/PMC7372807/ /pubmed/32689945 http://dx.doi.org/10.1186/s12866-020-01898-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Tian, Xuebin
Wang, Qiongdan
Perlaza-Jiménez, Laura
Zheng, Xiangkuo
Zhao, Yajie
Dhanasekaran, Vijay
Fang, Renchi
Li, Jiahui
Wang, Chong
Liu, Haiyang
Lithgow, Trevor
Cao, Jianming
Zhou, Tieli
First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling
title First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling
title_full First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling
title_fullStr First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling
title_full_unstemmed First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling
title_short First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling
title_sort first description of antimicrobial resistance in carbapenem-susceptible klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372807/
https://www.ncbi.nlm.nih.gov/pubmed/32689945
http://dx.doi.org/10.1186/s12866-020-01898-1
work_keys_str_mv AT tianxuebin firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling
AT wangqiongdan firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling
AT perlazajimenezlaura firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling
AT zhengxiangkuo firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling
AT zhaoyajie firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling
AT dhanasekaranvijay firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling
AT fangrenchi firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling
AT lijiahui firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling
AT wangchong firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling
AT liuhaiyang firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling
AT lithgowtrevor firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling
AT caojianming firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling
AT zhoutieli firstdescriptionofantimicrobialresistanceincarbapenemsusceptibleklebsiellapneumoniaeafterimipenemtreatmentdrivenbyoutermembraneremodeling